|
Suppliers for CAS
871700-17-3
|
Properties | | CAS |
871700-17-3 | | Formula |
C26H23FIN5O4 |
|
13 Registered suppliers
Amadis Chemical Company Limited
P.R.China
More details are to be found here
Dayang Chem (Hangzhou) Co.,Ltd.
P.R.China
More details are to be found here
Hangzhou Keying Chem Co., Ltd.
P.R.China
More details are to be found here
Xingrui Industry Co., Limited
P.R.China
More details are to be found here
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C26H23FIN5O4
Molecular Weight: 615.3947932
HS Code: 29339900
Guangzhou Topwork Chemical Co., Ltd.
P.R.China
Molecular Formula: C26H23FIN5O4
Molecular Weight: 615.3947932
HS Code: 29339900
Aea.ltd
P.R.China
Molecular Formula: C26H23FIN5O4
Molecular Weight: 615.3947932
HS Code: 29339900
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
Molecular Formula: C26H23FIN5O4
Molecular Weight: 615.3947932
HS Code: 29339900
Finetech Industry Limited
P.R.China
More details are to be found here
Hangzhou Lingrui Chemical Co., Ltd.
P.R.China
More details are to be found here
BOC Sciences
USA
Description : A MEK inhibitor that suppresses MEK1 and MEK2 with IC50 of 0.92 and 1.8 nM and no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2. It has been approved by FDA, in combination with Tafilnar, for the treatment of metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation. - Molecular Weight :615.39
- Melting Point :299-301 °C
- Purity :≥98%
Molecular Formula : C26H23FIN5O4 Canonical SMILES : CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
InChI :
InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)
InChIKey :
LIRYPHYGHXZJBZ-UHFFFAOYSA-N
Appearance :
Off-White Solid
Synonyms :
GSK-1120212; GSK 1120212; GSK1120212; JTP74057; JTP 74057; JTP-74057; Mekinist
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : A MEK inhibitor that suppresses MEK1 and MEK2 with IC50 of 0.92 and 1.8 nM and no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2. It has been approved by FDA, in combination with Tafilnar, for the treatment of metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation. - Molecular Weight :615.39
- Melting Point :299-301 °C
- Purity :≥98%
Molecular Formula : C26H23FIN5O4 Canonical SMILES : CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
InChI :
InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)
InChIKey :
LIRYPHYGHXZJBZ-UHFFFAOYSA-N
Appearance :
Off-White Solid
Synonyms :
GSK-1120212; GSK 1120212; GSK1120212; JTP74057; JTP 74057; JTP-74057; Mekinist
More details are to be found here
Detailed information on the suppliers of
Trametinib |
_Co_Ltd_1_575.jpg){kind=logo}
details
details